Five international liver societies established a single, unified definition for acute-on-chronic liver failure, resolving longstanding regional diagnostic discrepancies that previously fragmented clinical research and patient care across North America, Europe, and Asia.
Doctors Use Same Diagnostic Thresholds for Liver Complications
- One Common Language: Doctors across the globe now use the exact same diagnostic thresholds to identify this severe liver complication, bridging past differences between American, European, and Asian medical guidelines.
- Catching Decline Earlier: The newly introduced category of organ dysfunction allows physicians to spot failing organs before they completely shut down, opening a wider window for medical intervention.
- Research Acceleration: Harmonized definitions enable researchers to conduct larger, multi-continental clinical trials that can more rapidly translate into improved treatments for patients worldwide.
Global Societies Resolve Longstanding Diagnostic Fragmentation
For years, medical professionals struggled with conflicting regional frameworks when diagnosing acute-on-chronic liver failure (ACLF), a potentially fatal condition where an underlying chronic liver disease suddenly exacerbates due to an acute injury such as an alcohol binge or viral infection, Medscape reported alongside coverage from STAT News and UA.News.
Debbie Shawcross, MBBS, PhD, of King’s College London, introduced the historic consensus during a session at The Liver Meeting 2026 hosted by the American Association for the Study of Liver Diseases (AASLD).
“This is the foundation that we can [use to] improve clinical care for patients with ACLF, we can accelerate research, we can develop urgently needed therapies, and we can improve outcomes for patients worldwide,” said Debbie Shawcross, MBBS, PhD, of King's College London.
Jasmohan S. Bajaj, MD, of Virginia Commonwealth University, stated that prior regional definitions created scientific friction. Five liver societies from around the world have agreed upon a single definition of acute-on-chronic liver failure, resolving longstanding regional differences, Medscape reported. Bajaj stated that this regional variance caused fragmentation and a loss of scientific credibility.
Diagnostic Criteria and Severity Grading Systems
Under the newly published consensus in Hepatology, diagnosing ACLF requires advanced chronic liver disease of fibrosis stage F3 or higher, liver failure indicated by a bilirubin level of at least 5 mg/dL and an international normalized ratio (INR) of at least 1.5, alongside the dysfunction or failure of at least one extrahepatic organ, Medscape noted. Severity is then categorized into three distinct grades.
Grade 1 ACLF involves liver failure plus dysfunction of one extrahepatic organ, while grade 2 requires failure of any single extrahepatic organ. Grade 3 is defined as liver failure paired with the failure of two or more extrahepatic organs. Kavish R. Patidar, DO, of Houston Methodist Hospital, explained to Medscape that recognizing organ dysfunction prior to full organ failure represents a major clinical advancement for timely patient triage and potential liver transplantation consideration.
| ACLF Severity Grade | Required Liver Criteria | Extrahepatic Organ Involvement |
|---|---|---|
| Grade 1 | Bilirubin ≥5 mg/dL + INR ≥1.5 (F3+ Fibrosis) | Dysfunction of 1 extrahepatic organ |
| Grade 2 | Bilirubin ≥5 mg/dL + INR ≥1.5 (F3+ Fibrosis) | Failure of 1 extrahepatic organ |
| Grade 3 | Bilirubin ≥5 mg/dL + INR ≥1.5 (F3+ Fibrosis) | Failure of ≥2 extrahepatic organs |
Clinical Impact Depends on Future Global Studies
Elliot B. Tapper, MD, of the University of Michigan, pointed out to Medscape that while the consensus creates immediate harmony for researchers and medical journals, its direct impact on everyday patient care will take time to materialize as larger global studies unfold.
Jasmohan S. Bajaj, MD, of Virginia Commonwealth University, who co-chaired the effort, explained that future phase 1 and 2a trials will prioritize safety and target engagement, whereas phase 2b and 3 trials will measure survival outcomes with and without liver transplantation.
“Achieving consensus on the definition of ACLF improves the generalizability of research across the globe,” said Elliot B. Tapper, MD, of the University of Michigan.
However, clinical debate remains regarding edge cases. Alberto Farias, MD, PhD, of the University of São Paulo, Brazil, raised concerns during the meeting regarding patients experiencing isolated liver failure who carry a high short-term mortality risk but technically fall outside the new definition due to a lack of extrahepatic organ involvement, Medscape reported.
Patidar also emphasized that the criteria still require rigorous prospective validation across diverse international patient populations and varied healthcare delivery environments.
Future Directions in Pediatric and Global Hepatology
During the consensus rollout, Jasmohan S. Bajaj, MD, of Virginia Commonwealth University, urged the working groups to include pediatric populations in upcoming iterations because children's physiological parameters differ from adults, Medscape noted. Responding to the breadth of the initiative, Mark Sonderup, MBChB, PhD, of the University of Cape Town, South Africa, remarked that the liver community had successfully de-Babelized its nomenclature to establish a unified global standard for clinical research.
References
- American Association for the Study of Liver Diseases (AASLD) & Hepatology Journal – Global Consensus on Acute-on-Chronic Liver Failure Definition.
- STAT News – Acute-on-chronic liver failure gets new, global definition.
- Medscape Medical News – Global Liver Societies Agree on One Definition of Acute-on-Chronic Liver Failure.
- UA.News – Experts agree on acute-on-chronic liver failure definition reporting.
